Literature DB >> 3607030

Nucleation of actin polymerization by villin and elongation at subcritical monomer concentration.

A Weber, J Northrop, M F Bishop, F A Ferrone, M S Mooseker.   

Abstract

We have obtained a quantitative description of villin-nucleated actin polymerization in physiological salt by determining the concentrations of free villin (V), villin-actin monomer (VA), villin-actin dimer (VA2), and villin-actin oligomer (VAn). Over a range of actin-villin ratios from 0.1 to 20 we determined the concentration of actin-bound villin by measuring the low-intensity pyrenylactin fluorescence of the two terminal actins in each villin-actin polymer. (To this end we first showed that each villin-actin oligomer and polymer contains two low-intensity pyrenylactin molecules.) We determined the concentration of free villin using a calibrated cutting activity assay. The pattern of increase in bound villin together with the pattern of increase in high-intensity pyrenylactin fluorescence with increasing G-actin concentration indicated, first, that villin-actin monomers were not formed at detectable levels even at a 12-fold villin excess over actin. Second, there was no stoichiometric villin-actin dimer formation at actin-villin ratios of 2. Instead there was an equilibrium between free villin, VA2, and VAn. Defining K1 = [VA]/[V][A] and K2 = [VA2]/[VA][A], a good fit of the data was obtained with K1 much less than K2 and a value of K1K2 = Kv = 10(12)-10(13) M-2 = [VA2]/[V][A]2, i.e., 1/Kv1/2 = (0.3-1) X 10(-6) M. We have assumed here that the monomer binding constant of VA2 to form VA3 was equal to the monomer binding constant of pointed filament ends, K infinity = 1/c infinity, obtained as described below.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3607030     DOI: 10.1021/bi00383a019

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Characterization of the actin filament capping state in human erythrocyte ghost and cytoskeletal preparations.

Authors:  P A Kuhlman
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

Review 2.  Actin and pollen tube growth.

Authors:  L Vidali; P K Hepler
Journal:  Protoplasma       Date:  2001       Impact factor: 3.356

3.  ATPase kinetics of the Dictyostelium discoideum myosin II motor domain.

Authors:  P A Kuhlman; C R Bagshaw
Journal:  J Muscle Res Cell Motil       Date:  1998-06       Impact factor: 2.698

4.  Memories of Annemarie Weber.

Authors:  Clara Franzini-Armstrong
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

5.  How Listeria exploits host cell actin to form its own cytoskeleton. II. Nucleation, actin filament polarity, filament assembly, and evidence for a pointed end capper.

Authors:  L G Tilney; D J DeRosier; A Weber; M S Tilney
Journal:  J Cell Biol       Date:  1992-07       Impact factor: 10.539

6.  Chemoattractant-stimulated polymorphonuclear leukocytes contain two populations of actin filaments that differ in their spatial distributions and relative stabilities.

Authors:  L Cassimeris; H McNeill; S H Zigmond
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

7.  Actin filament nucleation by the bacterial pathogen, Listeria monocytogenes.

Authors:  L G Tilney; P S Connelly; D A Portnoy
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

8.  Tropomodulin caps the pointed ends of actin filaments.

Authors:  A Weber; C R Pennise; G G Babcock; V M Fowler
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

9.  How actin binds and assembles onto plasma membranes from Dictyostelium discoideum.

Authors:  M A Schwartz; E J Luna
Journal:  J Cell Biol       Date:  1988-07       Impact factor: 10.539

10.  Adducin is an in vivo substrate for protein kinase C: phosphorylation in the MARCKS-related domain inhibits activity in promoting spectrin-actin complexes and occurs in many cells, including dendritic spines of neurons.

Authors:  Y Matsuoka; X Li; V Bennett
Journal:  J Cell Biol       Date:  1998-07-27       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.